2Zoppellaro G, Granziera S, Padayattil Jose S, et al. Minimizing the risk of hemorThagie stroke during anticoagulant therapy for atrial fibrillation [ J ]. Expert Opin Drug Saf, 2015 : 1-13.
3Gage BF, van Walraven C, Pearee L, et al. Selecting patients with atrial fibrillation for anticoagulation : stroke risk stratification in pa- tients taking aspirin [ J 1. Circulation, 2004, 110 ( 16 ) : 2287 -2292.
5Sakai K, Kimura K, lghtJehi Y, et ah Five years after mortality of atrial fibrillation in community-dwelling Japanese aged 40 years or older in Japan [ J]. Riusho Shinkeigaku, 2015,55 ( 3 ) : 178-181.
6Sohara H, Amitani S, Kurose M, et al. Atrial fibrillation activates platelets and coagulation in time-dependent manner: a study in patients with paroxysmal atrial fibrillation[ J]. J Am Coil Cardiol,1997,29( 1 ) :106-112.
7Kumagai T, Ma/suura Y, Yamamoto T, et al. Risk factors for lel:l atrial thrombus from transesophageal echocardiography finditgs in isehemic stroke patients [J]. Fukushima J Med Sci, 2015, 60(2) : 154-158.
8O/esen JB, Lip GY, Lindhardsen J, et al. Risks of thrnmboembo- lism and bleeding with thromboprophylaxis in palients wid atrial fibrillation: A net clinieal benefit analysis using a " real world" nationwide cohort study [ J]. Thromb Haemost, 2011,106 (4) : 739-749.
9CammA J, Kirchhof P, l,ip GY, eta/. Guidelines for the mamrge- ment of atrial fibrillation : the task fi)i:e for the management of atrial filwillalion of the European Society of Cardiology, (ESC) [ J ]. Eur Heart J, 2010,31 (19) :2369-2429.
10Yamamoto S, Suwa M, lto T, et ah Comparison of tiequeney of thromboembnlie events and eehoeardiographie findings in patients with chronic nonvalvular atrial fibrillation and cmrse versus fine electroeardiog-aphie fibrillatory waves [ J ]. Am J Ca,diol, 2005, 96(3) :408-411.
